Patent · US Active

DPP IV inhibitors

US7803819B2 · kind B2 · utility

0Cited by

7References

21Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Markus Boehringer
Daniel Hunziker
Holger Kuehne · Soest, DE
Bernd Loeffler · Oberrimsingen, DE
Ramakanth Sarabu · Towaco, US
Hans Peter Wessel · Heitersheim, DE

Key dates

Filing date	Jul 17, 2007
Grant date	Sep 28, 2010
Priority date	—
Expiry date	Mar 16, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/4825
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I)wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.